Navigation Links
Ardea Biosciences to Present at Wedbush Securities Life Sciences Conference
Date:8/10/2011

SAN DIEGO, Aug. 10, 2011 /PRNewswire/ -- Ardea Biosciences, Inc. (Nasdaq: RDEA) announced today that Barry D. Quart, PharmD, president and chief executive officer, will present at the Wedbush Securities 2011 Life Sciences Management Access Conference in New York, NY at 12:40 p.m. EDT on Tuesday, August 16, 2011.

This presentation will be webcast and can be accessed on the Investor Relations section of Ardea's website at www.ardeabio.com. Please connect to Ardea's website several minutes prior to the start of the broadcast to ensure adequate time for any software download that may be necessary.

About Ardea Biosciences, Inc.

Ardea Biosciences, Inc., of San Diego, California, is a biotechnology company focused on the development of small-molecule therapeutics for the treatment of serious diseases. Lesinurad (RDEA594), our lead product candidate for the chronic management of hyperuricemia in patients with gout, is a once-daily, oral inhibitor of the URAT1 transporter.  We have completed Phase 2b clinical studies of lesinurad and continue to advance the drug in longer term extensions in preparation for Phase 3 development.  Our next-generation URAT1 inhibitor, RDEA3170, is currently in preclinical development. BAY 86-9766 (RDEA119) is a potent and specific inhibitor of mitogen-activated ERK kinase (MEK) for the treatment of cancer being developed under a global license agreement with Bayer HealthCare. BAY 86-9766 (RDEA119) is currently in a Phase 2 study in patients with hepatocellular carcinoma in combination with sorafenib and a Phase 1/Phase 2 study in patients with advanced pancreatic cancer in combination with gemcitabine.

Statements contained in this press release regarding matters that are not historical facts are "forward-looking statements" within the meaning of the Private Securities Litiga
'/>"/>

SOURCE Ardea Biosciences, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Ardea Biosciences Provides Additional Results From a Phase 2b Study of Lesinurad in Combination With Allopurinol at the Annual European Congress of Rheumatology
2. Ardea Biosciences to Present at Two Upcoming Investor Conferences
3. Ardea Biosciences Earns $15 Million Payment from Bayer HealthCare AG for Achievement of Important Clinical Milestone in Ongoing Collaboration
4. Ardea Announces Data on MEK Inhibitor BAY 86-9766 (RDEA119) to be Presented at EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
5. Ardea Biosciences to Present at Four Upcoming Investor Conferences
6. Ardea Biosciences Reports Recent Accomplishments; Provides 2010 Outlook; Announces Fourth Quarter and Full-Year 2009 Financial Results and 2010 Financial Guidance
7. Ardea Biosciences to Present at Two Upcoming Investor Conferences
8. Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results
9. Ardea Biosciences Presents Preclinical Anti-Inflammatory Data on its Lead MEK Inhibitor, RDEA119, at the ACG 2008 Annual Meeting
10. Ardea Biosciences to Present Data on Lead MEK Inhibitor, RDEA119, at American College of Gastroenterology Annual Scientific Meeting
11. Ardea Biosciences Advances Lead Product Candidate for the Treatment of Gout, RDEA594, Into Phase 1 Clinical Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... ALBANY, N.Y. , March 5, 2015  AMRI ... Michael Pettersson , fills the newly created position of ... Christopher Conway , Senior Vice President of Global ... Mr. Pettersson will lead the international sales team in ... market share in targeted market segments. Mr. Pettersson will ...
(Date:3/5/2015)... - Cross reference: Picture is ... - Hitachi Medical Systems Europe è ... OASIS* all,ECR 2015. Si tratta di un sistema ... T che migliora la capacità diagnostica dei sistemi già ... del paziente. Le nuove funzionalità di OASIS permettono una ...
(Date:3/5/2015)... PRINCETON, N.J. , March 5, 2015 ... late stage biopharmaceutical company committed to developing products that ... oncology and biodefense, announced today that its President and ... will give a corporate presentation at the 27 th ... California , on Tuesday, March 10, 2015 at ...
Breaking Medicine Technology:AMRI Hires VP of International Sales 2Hitachi Medical Systems Europe lancia la nuova generazione di OASIS*: Il sistema di RM aperta ad alto campo da 1.2 T. Ancora più valore al paziente 2Hitachi Medical Systems Europe lancia la nuova generazione di OASIS*: Il sistema di RM aperta ad alto campo da 1.2 T. Ancora più valore al paziente 3Hitachi Medical Systems Europe lancia la nuova generazione di OASIS*: Il sistema di RM aperta ad alto campo da 1.2 T. Ancora più valore al paziente 4Soligenix to Present at the 27th Annual ROTH Conference 2Soligenix to Present at the 27th Annual ROTH Conference 3
... median survival vs. ... parallel external controls -, IRVINE, Calif., Nov. 2 ... from the Phase 2 study of,its investigational agent IDM-2101 which showed ... responses,and showed a positive survival trend in patients with non-small cell ...
... In a move to improve,significantly the safety ... emergency medical information service, has joined,the Alzheimer,s Association ... offer MedicAlert(R) + Safe Return(R). Currently, there are ... almost 10 million,people caring for someone with Alzheimer,s ...
Cached Medicine Technology:IDM Pharma Announces IDM-2101 Updated Phase 2 Results Show Treatment Well Tolerated With Positive Survival Trend in Lung Cancer Patients 2IDM Pharma Announces IDM-2101 Updated Phase 2 Results Show Treatment Well Tolerated With Positive Survival Trend in Lung Cancer Patients 3IDM Pharma Announces IDM-2101 Updated Phase 2 Results Show Treatment Well Tolerated With Positive Survival Trend in Lung Cancer Patients 4MedicAlert Foundation Joins The Alzheimer's Association to Offer MedicAlert(R) + Alzheimer's Association Safe Return(R) - Live 24-Hour Emergency Response for Wandering and Medical Emergencies 2MedicAlert Foundation Joins The Alzheimer's Association to Offer MedicAlert(R) + Alzheimer's Association Safe Return(R) - Live 24-Hour Emergency Response for Wandering and Medical Emergencies 3
(Date:3/5/2015)... (PRWEB) March 06, 2015 In 2014, ... being first–in-class. AstraZeneca tops the list scoring 4 drug ... over 25% of all FDA approved drug products, followed ... mechanisms such as anti-PCSK9, anti-PD1 and CDK inhibitors keep ... approved by the FDA to treat metastatic melanoma, and ...
(Date:3/5/2015)... AxoGen, Inc. (NASDAQ: AXGN) , a ... repair market, reported record revenue of $4.79 million for ... $2.98 million in the year-ago fourth quarter demonstrating the ... “Our strong fourth quarter revenue growth reflects the market’s ... is driving increased surgeon adoption of our unique product ...
(Date:3/5/2015)... HomeCEUConnection.com is proud to support ... on their nutrition CEUs. To raise awareness ... HomeCEUConnection.com is offering 10% off selected nutrition ... NUTRITION2015 . , High Quality Continuing Education ... high-quality continuing education courses for Physical Therapists, ...
(Date:3/5/2015)... CA (PRWEB) March 05, 2015 TCS ... clinical solutions for the population health management arena, is ... enhanced case management software, ACUITY Advanced Care™ (ACUITY) version ... interface, improved performance and the advantages of automation. , ... p.m. ET, will be led by Jeff Frater, RN, ...
(Date:3/5/2015)... 05, 2015 University of Western ... in 1904, has launched a new center of ... changes. The Northwest Center for Lifestyle and Functional ... community outreach, and conduct research in the areas ... and nutrition. The center will target efforts on ...
Breaking Medicine News(10 mins):Health News:World Pharma Business and Large-Cap Companies Discussed by MP Advisors in In-demand Study Available at MarketPublishers.com 2Health News:World Pharma Business and Large-Cap Companies Discussed by MP Advisors in In-demand Study Available at MarketPublishers.com 3Health News:AxoGen, Inc. Reports 61% Revenue Growth for the 2014 Fourth Quarter 2Health News:AxoGen, Inc. Reports 61% Revenue Growth for the 2014 Fourth Quarter 3Health News:AxoGen, Inc. Reports 61% Revenue Growth for the 2014 Fourth Quarter 4Health News:HomeCEUConnection.com Offers Nutrition CEUs this March to Celebrate Nutrition Month 2Health News:Complimentary Webinar to Explore Enhanced Version of Premier Case Management Software 2Health News:Complimentary Webinar to Explore Enhanced Version of Premier Case Management Software 3Health News:University of Western States Launches Northwest Center for Lifestyle and Functional Medicine 2
... Nephros, Inc. (Amex: NEP ), a ... for therapeutic applications, infection control, and water purification, ... the NYSE Alternext US LLC (formerly, the American ... AMEX,s intention to delist the Company,s common stock ...
... has led to a considerable reduction in infection rates, ... pneumococcal meningitis, a potentially life-threatening infection, have declined substantially ... new study shows. , The declines have been seen ... in adults, suggesting a herd immunity effect, the researchers ...
... statement of Matthew L. Myers, President, Campaign for ... U.S. House of Representatives today delivered a tremendous ... federal tobacco taxes, including a 61-cent increase in ... of the State Children,s Health Insurance Program (SCHIP). ...
... SOKO Fitness & Spa,Group, Inc. (OTC Bulletin Board: ... in Northern China, today reported that the company ... 31, 2008 and the first quarter,ended August 31, ... the,auditors. The company also announced it expects ...
... Healthcare Services, Inc. (NYSE: AHS ), the largest ... quarterly conference call to discuss fourth quarter and year end ... Time. The company expects to issue an earnings news ... of market at approximately 4:00 p.m. Eastern Time. A live ...
... Bipartisan Support for SCHIP ReauthorizationWASHINGTON, Jan. 14 The ... of the Speaker of the House: Divided We Fail ... and SEIU) , "On behalf of Divided We ... and strengthen the State Children,s Health Insurance Program (SCHIP). ...
Cached Medicine News:Health News:Nephros Receives Notice of Intention to Delist from AMEX 2Health News:Nephros Receives Notice of Intention to Delist from AMEX 3Health News:Nephros Receives Notice of Intention to Delist from AMEX 4Health News:Meningitis Vaccine Seems to Work Like a Charm 2Health News:Meningitis Vaccine Seems to Work Like a Charm 3Health News:U.S. House Acts to Protect Kids, Save Lives by Increasing Federal Tobacco Taxes 2Health News:SOKO Fitness & Spa Group Announces Changes to Previously Issued Financial Statements 2Health News:SOKO Fitness & Spa Group Announces Changes to Previously Issued Financial Statements 3Health News:SOKO Fitness & Spa Group Announces Changes to Previously Issued Financial Statements 4Health News:SOKO Fitness & Spa Group Announces Changes to Previously Issued Financial Statements 5Health News:AMN Healthcare Services to Host 2008 Fourth Quarter & Year End Earnings Conference Call on Thursday, February 26, 2009 2Health News:Health Care For 11 Million Children 2Health News:Health Care For 11 Million Children 3Health News:Health Care For 11 Million Children 4
Inquire...
Inquire...
The Optima III 45 cm line of laparoscopic hand instruments is ideal for operative laparoscopic/endoscopic procedures or when a longer instrument is needed....
The Optima III line of laparoscopic hand instruments provides a well-crafted set of instruments designed for strength and durability....
Medicine Products: